Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $2.00 billion. The enterprise value is $1.32 billion.

Market Cap	2.00B
Enterprise Value	1.32B

Important Dates

The last earnings date was Monday, July 28, 2025, after market close.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	n/a

Share Statistics

DYN has 142.26 million shares outstanding. The number of shares has increased by 44.14% in one year.

Current Share Class	142.26M
Shares Outstanding	142.26M
Shares Change (YoY)	+44.14%
Shares Change (QoQ)	+3.60%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	80.82%
Float	122.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.65
P/TBV Ratio	3.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.83, with a Debt / Equity ratio of 0.21.

Current Ratio	16.83
Quick Ratio	16.49
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4,690.74

Financial Efficiency

Return on equity (ROE) is -61.32% and return on invested capital (ROIC) is -36.91%.

Return on Equity (ROE)	-61.32%
Return on Assets (ROA)	-35.45%
Return on Invested Capital (ROIC)	-36.91%
Return on Capital Employed (ROCE)	-64.13%
Revenue Per Employee	n/a
Profits Per Employee	-$2.16M
Employee Count	191
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.55% in the last 52 weeks. The beta is 1.10, so DYN's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-58.55%
50-Day Moving Average	10.65
200-Day Moving Average	14.55
Relative Strength Index (RSI)	65.66
Average Volume (20 Days)	2,506,203

Short Selling Information

The latest short interest is 17.14 million, so 12.05% of the outstanding shares have been sold short.

Short Interest	17.14M
Short Previous Month	16.31M
Short % of Shares Out	12.05%
Short % of Float	13.97%
Short Ratio (days to cover)	5.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-440.93M
Pretax Income	-257.40M
Net Income	-412.89M
EBITDA	-439.04M
EBIT	-440.93M
Earnings Per Share (EPS)	-$3.87

Balance Sheet

The company has $683.93 million in cash and $121.08 million in debt, giving a net cash position of $562.85 million or $3.96 per share.

Cash & Cash Equivalents	683.93M
Total Debt	121.08M
Net Cash	562.85M
Net Cash Per Share	$3.96
Equity (Book Value)	571.45M
Book Value Per Share	5.00
Working Capital	656.48M

Cash Flow

In the last 12 months, operating cash flow was -$359.56 million and capital expenditures -$2.37 million, giving a free cash flow of -$361.93 million.

Operating Cash Flow	-359.56M
Capital Expenditures	-2.37M
Free Cash Flow	-361.93M
FCF Per Share	-$2.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.14%
Shareholder Yield	-44.14%
Earnings Yield	-21.92%
FCF Yield	-19.22%

Analyst Forecast

The average price target for DYN is $34.93, which is 148.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.93
Price Target Difference	148.35%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-39.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1